Xenetic Biosciences Inc. (XBIO)
NASDAQ · Healthcare
Xenetic Biosciences Inc. Revenue 2012–2025
Xenetic Biosciences Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Xenetic Biosciences Inc. revenue for the quarter ending March 31, 2026 was 806923, a 36.01% increase year-over-year.
- Xenetic Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 3.0 M, a 22.51% increase year-over-year.
- Xenetic Biosciences Inc. annual revenue for 2025 was 3.0 M, a 19.04% increase from 2024.
- Xenetic Biosciences Inc. annual revenue for 2024 was 2.5 M, a 1.56% decrease from 2023.
- Xenetic Biosciences Inc. annual revenue for 2023 was 2.5 M, a 48.80% increase from 2022.
- Xenetic Biosciences Inc. annual revenue for 2022 was 1.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Xenetic Biosciences Inc. Earnings — FAQ
Xenetic Biosciences Inc. (XBIO) earnings over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XBIO's earnings history?
The chart and table above show Xenetic Biosciences Inc.'s earnings by year and by quarter, including the growth rate.